130 related articles for article (PubMed ID: 36462957)
1. Human MD2 deficiency-an inborn error of immunity with pleiotropic features.
Li Y; Yu Z; Schenk M; Lagovsky I; Illig D; Walz C; Rohlfs M; Conca R; Muise AM; Snapper SB; Uhlig HH; Garty BZ; Klein C; Kotlarz D
J Allergy Clin Immunol; 2023 Mar; 151(3):791-796.e7. PubMed ID: 36462957
[TBL] [Abstract][Full Text] [Related]
2. Heme induces inflammatory injury by directly binding to the complex of myeloid differentiation protein 2 and toll-like receptor 4.
Lin J; Lin K; Huang L; Jiang Y; Ding X; Luo W; Samorodov AV; Pavlov VN; Liang G; Qian J; Wang Y
Toxicol Lett; 2022 Nov; 370():15-23. PubMed ID: 36115635
[TBL] [Abstract][Full Text] [Related]
3. Biallelic TLR4 deficiency in humans.
Capitani M; Al-Shaibi AA; Pandey S; Gartner L; Taylor H; Hubrack SZ; Agrebi N; Al-Mohannadi MJ; Al Kaabi S; Vogl T; Roth J; Kotlarz D; Klein C; Charles AK; Vijayakumar V; Karim MY; George B; Travis SP; Elawad M; Lo B; Uhlig HH
J Allergy Clin Immunol; 2023 Mar; 151(3):783-790.e5. PubMed ID: 36462956
[TBL] [Abstract][Full Text] [Related]
4. Sialyl residues modulate LPS-mediated signaling through the Toll-like receptor 4 complex.
Feng C; Stamatos NM; Dragan AI; Medvedev A; Whitford M; Zhang L; Song C; Rallabhandi P; Cole L; Nhu QM; Vogel SN; Geddes CD; Cross AS
PLoS One; 2012; 7(4):e32359. PubMed ID: 22496731
[TBL] [Abstract][Full Text] [Related]
5. Activation of Toll-like receptors by Burkholderia pseudomallei.
West TE; Ernst RK; Jansson-Hutson MJ; Skerrett SJ
BMC Immunol; 2008 Aug; 9():46. PubMed ID: 18691413
[TBL] [Abstract][Full Text] [Related]
6. Curcumin Analog L48H37 Prevents Lipopolysaccharide-Induced TLR4 Signaling Pathway Activation and Sepsis via Targeting MD2.
Wang Y; Shan X; Dai Y; Jiang L; Chen G; Zhang Y; Wang Z; Dong L; Wu J; Guo G; Liang G
J Pharmacol Exp Ther; 2015 Jun; 353(3):539-50. PubMed ID: 25862641
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide (LPS) directly suppresses growth hormone receptor (GHR) expression through MyD88-dependent and -independent Toll-like receptor-4/MD2 complex signaling pathways.
Dejkhamron P; Thimmarayappa J; Kotlyarevska K; Sun J; Lu C; Bonkowski EL; Denson LA; Menon RK
Mol Cell Endocrinol; 2007 Aug; 274(1-2):35-42. PubMed ID: 17601656
[TBL] [Abstract][Full Text] [Related]
8. The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF.
Figueroa L; Xiong Y; Song C; Piao W; Vogel SN; Medvedev AE
J Immunol; 2012 May; 188(9):4506-15. PubMed ID: 22474023
[TBL] [Abstract][Full Text] [Related]
9. TLR4 and MD2 variation among horses with differential TNFα baseline concentrations and response to intravenous lipopolysaccharide infusion.
Mukhopadhyay A; Cook SR; SanMiguel P; Ekenstedt KJ; Taylor SD
Sci Rep; 2023 Jan; 13(1):1486. PubMed ID: 36707633
[TBL] [Abstract][Full Text] [Related]
10. Sulforaphane inhibits the engagement of LPS with TLR4/MD2 complex by preferential binding to Cys133 in MD2.
Koo JE; Park ZY; Kim ND; Lee JY
Biochem Biophys Res Commun; 2013 May; 434(3):600-5. PubMed ID: 23583403
[TBL] [Abstract][Full Text] [Related]
11. Oxidized phospholipid inhibition of toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition.
Erridge C; Kennedy S; Spickett CM; Webb DJ
J Biol Chem; 2008 Sep; 283(36):24748-59. PubMed ID: 18559343
[TBL] [Abstract][Full Text] [Related]
12. Suppression of Toll-like receptor 4 activation by caffeic acid phenethyl ester is mediated by interference of LPS binding to MD2.
Kim SY; Koo JE; Seo YJ; Tyagi N; Jeong E; Choi J; Lim KM; Park ZY; Lee JY
Br J Pharmacol; 2013 Apr; 168(8):1933-45. PubMed ID: 23231684
[TBL] [Abstract][Full Text] [Related]
13. Celastrol blocks binding of lipopolysaccharides to a Toll-like receptor4/myeloid differentiation factor2 complex in a thiol-dependent manner.
Lee JY; Lee BH; Kim ND; Lee JY
J Ethnopharmacol; 2015 Aug; 172():254-60. PubMed ID: 26116162
[TBL] [Abstract][Full Text] [Related]
14. An MD2-derived peptide promotes LPS aggregation, facilitates its internalization in THP-1 cells, and inhibits LPS-induced pro-inflammatory responses.
Tandon A; Harioudh MK; Ishrat N; Tripathi AK; Srivastava S; Ghosh JK
Cell Mol Life Sci; 2018 Jul; 75(13):2431-2446. PubMed ID: 29313060
[TBL] [Abstract][Full Text] [Related]
15. Human conjunctival epithelial cells lack lipopolysaccharide responsiveness due to deficient expression of MD2 but respond after interferon-gamma priming or soluble MD2 supplementation.
Talreja J; Dileepan K; Puri S; Kabir MH; Segal DM; Stechschulte DJ; Dileepan KN
Inflammation; 2005 Dec; 29(4-6):170-81. PubMed ID: 17093906
[TBL] [Abstract][Full Text] [Related]
16. Arachidonic acid inhibits inflammatory responses by binding to myeloid differentiation factor-2 (MD2) and preventing MD2/toll-like receptor 4 signaling activation.
Zhang Y; Chen H; Zhang W; Cai Y; Shan P; Wu D; Zhang B; Liu H; Khan ZA; Liang G
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165683. PubMed ID: 31953218
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 Tat Protein Induces Production of Proinflammatory Cytokines by Human Dendritic Cells and Monocytes/Macrophages through Engagement of TLR4-MD2-CD14 Complex and Activation of NF-κB Pathway.
Ben Haij N; Planès R; Leghmari K; Serrero M; Delobel P; Izopet J; BenMohamed L; Bahraoui E
PLoS One; 2015; 10(6):e0129425. PubMed ID: 26090662
[TBL] [Abstract][Full Text] [Related]
18. Recent progress in the discovery of myeloid differentiation 2 (MD2) modulators for inflammatory diseases.
Chen L; Fu W; Zheng L; Wang Y; Liang G
Drug Discov Today; 2018 Jun; 23(6):1187-1202. PubMed ID: 29330126
[TBL] [Abstract][Full Text] [Related]
19. Moraxella catarrhalis activates murine macrophages through multiple toll like receptors and has reduced clearance in lungs from TLR4 mutant mice.
Hassan F; Ren D; Zhang W; Merkel TJ; Gu XX
PLoS One; 2012; 7(5):e37610. PubMed ID: 22662179
[TBL] [Abstract][Full Text] [Related]
20. Macrophage-derived myeloid differentiation protein 2 plays an essential role in ox-LDL-induced inflammation and atherosclerosis.
Chen T; Huang W; Qian J; Luo W; Shan P; Cai Y; Lin K; Wu G; Liang G
EBioMedicine; 2020 Mar; 53():102706. PubMed ID: 32151799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
